Opioid Agonist Treatment Prescriber Training
Opioid Agonist Treatment (methadone and buprenorphine/naloxone) Prescriber Training, Mentoring and Auditing.
The CPSM, in partnership with the CRNM and the CPhM, supports an interdisciplinary scientific planning committee that developed and maintains a 2 day, in-person, accredited training program for physicians, pharmacists, nurse practitioners, nurses and allied health professionals who wish to become involved in treating individuals with opioid use disorder.
This program, in its pilot format, became a major component of an application that secured a federal/provincial grant of just over $1 million over four years to expand this work beyond the Winnipeg-based training of Opioid Agonist Treatment (OAT) providers. The College is using this funding to:
- Provide Opioid Agonist Treatment (OAT) training sessions eight times per year, including two rural and two remote sessions per fiscal year.
- Conduct audits of new (physician) OAT prescribers who have completed their first year in OAT practice.
- Provide mentorship to new and existing Opioid Agonist Treatment prescribers.
- Develop a CPSM Buprenorphine/Naloxone Recommended Practices Manual, as well as update the existing CPSM Methadone Recommended Practices Manual
UPCOMING TRAINING WORKSHOPS
Click on preferred date below for further information and to register.
OAT March 12 & 13, 2020 in Norway House/Cross Lake - CANCELLED
Further Opioid Agonist Therapy (OAT) Training Information